Joint Formulary & PAD

Etelcalcetide - Chronic Kidney Disease

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Injection
Associated Icons :
Restrictions / Comments :
Important

Not on Surrey Heartlands Trust formularies. Trusts with renal centres (locally this is Epsom, Frimley & Brighton) will retain prescribing responsibility’.

Documents :
 

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Etelcalcetide
Indication :
Chronic Kidney Disease
Group Name :
Keywords :
Brand Names Include :
Important Information :

Secondary hyperparathyroidism in patients with chronic kidney disease on haemodialysis

Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
1

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Etelcalcetide is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Chronic Kidney Disease.